title: BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.
abstract: Host cell factors can either positively or negatively regulate the assembly and egress of HIV-1 particles from infected cells. Recent reports have identified a previously uncharacterized transmembrane protein, tetherin/CD317/BST-2, as a crucial host restriction factor that acts during a late budding step in HIV-1 replication by inhibiting viral particle release. Although tetherin has been shown to promote the retention of nascent viral particles on the host cell surface, the precise molecular mechanisms that occur during and after these tethering events remain largely unknown. We here report that a RING-type E3 ubiquitin ligase, BCA2 (Breast cancer-associated gene 2; also called Rabring7, ZNF364 or RNF115), is a novel tetherin-interacting host protein that facilitates the restriction of HIV-1 particle production in tetherin-positive cells. The expression of human BCA2 in "tetherin-positive" HeLa, but not in "tetherin-negative" HOS cells, resulted in a strong restriction of HIV-1 particle production. Upon the expression of tetherin in HOS cells, BCA2 was capable of inhibiting viral particle production as in HeLa cells. The targeted depletion of endogenous BCA2 by RNA interference (RNAi) in HeLa cells reduced the intracellular accumulation of viral particles, which were nevertheless retained on the plasma membrane. BCA2 was also found to facilitate the internalization of HIV-1 virions into CD63(+) intracellular vesicles leading to their lysosomal degradation. These results indicate that BCA2 accelerates the internalization and degradation of viral particles following their tethering to the cell surface and is a co-factor or enhancer for the tetherin-dependent restriction of HIV-1 release from infected cells.
authors.affiliation: AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
authors.forename: Kei
authors.initials: K
authors.lastname: Miyakawa
authors.forename: Akihide
authors.initials: A
authors.lastname: Ryo
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Murakami
authors.forename: Kenji
authors.initials: K
authors.lastname: Ohba
authors.forename: Shoji
authors.initials: S
authors.lastname: Yamaoka
authors.forename: Mitsunori
authors.initials: M
authors.lastname: Fukuda
authors.forename: John
authors.initials: J
authors.lastname: Guatelli
authors.forename: Naoki
authors.initials: N
authors.lastname: Yamamoto
mesh_terms: D015703:Antigens, CD / Q000276:immunology / Q000502:physiology*; D002460:Cell Line; D004705:Endocytosis; D058851:GPI-Linked Proteins; D015497:HIV-1 / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007113:Immunity, Innate; D008247:Lysosomes / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000276:immunology / Q000502:physiology*; D044767:Ubiquitin-Protein Ligases / Q000276:immunology / Q000502:physiology*; D014771:Virion / Q000378:metabolism; D014779:Virus Replication; D000074010:Bone Marrow Stromal Antigen 2
chemical_list: D015703:Antigens, CD; D058851:GPI-Linked Proteins; D008562:Membrane Glycoproteins; D044767:Ubiquitin-Protein Ligases; C094572:BST2 protein, human; D000074010:Bone Marrow Stromal Antigen 2; C506934:RNF115 protein, human